[Vasoprotective effect of effective lipid-lowering therapy in patients with -segment elevation myocardial infarction].

Aim: To study the vasoprotective effects of atorvastatin depending on the achievement of the target level of low-density lipoprotein cholesterol (LDL-C) in patients with -segment elevation myocardial infarction (EMI) within 48 weeks of follow-up.

Materials And Methods: Included were 112 EMI patients who received atorvastatin 20-40-80 mg. On days 7-9 from the onset of the disease, after 24 and 48 weeks, ultrasound examination of the carotid arteries with RF technology and applanation tonometry were performed, the lipid profile was determined.